Data analysis tool for Multi-Omics

From Raw Data to Actionable Reports in Under 5 Minutes

In the race to bring precision medicine to the frontlines of healthcare, time is everything. Genomic analysis which was once a bottleneck has now entered a new era of speed, integration, and intelligence. At the forefront of this revolution stands PanOmiQ™, the world’s fastest multi-genomic platform.
Capable of processing Whole Genome Sequencing (WGS) data in under five minutes, PanOmiQ delivers high-resolution insights at unprecedented speed. But this isn’t just about velocity; it’s about what that speed enables: real-time pharmacogenomics reporting, comprehensive microbiome profiling, and seamless multi-omics integration.
With PanOmiQ, what once took hours or days can now happen during a coffee break.

Foundational Intelligence for Local Analysis

  • For labs, clinics, and research centers handling up to 1,000 samples per year.

  • Designed for local or FPGA-based deployment where internet-independent computation is required.

  • Handles multi-omics data analysis, including genomic, epigenomic, and microbiome datasets.

  • Supports PanOmiQ™️ standalone installation for on-premise use.

  • Ideal for pilot-scale sequencing programs, academic labs, and clinical R&D teams.

  • Optimized for low-latency analytics and data privacy with minimal infrastructure footprint.

  • Deployment modes: On-premise | Edge FPGA | Secure Cloud Sync (optional)

Scalable Performance for Expanding Operations

  • For regional labs, health networks, or biotech companies processing 1,000–10,000 samples annually.
  • FPGA and GPU hybrid compute architecture for accelerated AI processing.
  • Supports custom analysis modules, AI model fine-tuning, and edge deployment across multi-site facilities.
  • Integrates seamlessly with BioLIMS™️, PanAUM™️, and BioELR™️ for end-to-end data management and clinical connectivity.
  • Enables real-time collaboration between labs, clinicians, and research teams through secure cloud environments.
  • Expandable architecture for new omics modules and drug-response prediction algorithms.
  • Suitable for hospitals, national labs, and biopharma organizations adopting AI-driven precision health workflows.

The Apex of Intelligent Health Computing

  • For large-scale health systems, data centers, and global research programs handling 10,000+ samples per year.

  • Houses integrated access to PanAUM™️ for in silico drug discovery and biomarker modeling.

  • Genelio™️ embedded intelligence for conversational data access and real-time insight generation.

  • Includes AI-assisted clinical dashboards and virtual twin simulations for predictive medicine.

  • Supports federated learning to connect global data sources securely while maintaining compliance (GDPR, HIPAA, ISO 15189).

  • Designed for national-level precision medicine programs, pharma pipelines, and translational research hubs.

  • Comprehensive Package: Full BioAro software suite, hardware acceleration, AI orchestration, and technical deployment support.

Key Features & Capabilities

  • Automation & Ease of Use: Effortless data uploads, automated detection of rare diseases, health predispositions, and pharmacogenomic markers; results are delivered in clear, user-friendly formats.

  • AI-driven, parallel processing: High-speed, scalable analysis through parallel computing and AI, often completing WGS-to-report in under 5 minutes.

  • Multi-layered accuracy and reliability: Utilizes curated databases like dbSNP, ClinVar, ACMG, Orphanet, and OMIM; guarantees 98% coverage and high data precision.

  • Interactive, integrated dashboards: Delivers clinical-grade genomic, ancestry, polygenic, and microbiome scores via PDF/HTML/API with intuitive visualization.

Speed

WGS-to-report in <5 minutes, enabling population-scale analysis or rapid point-of-care decisions.

Accuracy

High-precision variant calling, annotation, and interpretation using curated databases and machine learning.

Multiomics Integration

Combine genomics + microbiome + clinical metadata into one interactive dashboard for holistic insight.

AI-Powered Insights

Smart prioritization of clinically actionable variants, risk scores, and biomarkers tailored to each user or patient.

Flexible Data Input

Compatible with FASTQ, VCF, or microbiome sequencing outputs that are integrated into a streamlined pipeline.

Interactive Reports

Clinical-grade genomics, ancestry, polygenic scores, microbiome indices; exportable via PDF, HTML, API.

What’s Next: Innovation & Expansion

  • PanDrugs Discovery: A computational tool to accelerate in-silico drug discovery, streamlining research from molecular hypothesis to validation.

  • BioTalk: Conversational Genomics: An AI-based assistant enabling users to converse with their genomic data in plain language—transforming difficult datasets into understandable insights.

  • Quantum-enhanced analysis: A “Quantum Edition” is coming soon—leveraging quantum computing to further speed up genomic sequencing and interpretation.